Clinical metabolomics paves the way towards future healthcare strategies.

Metabolomics is recognized as a powerful top-down system biological approach to understand genetic-environment-health paradigms paving new avenues to identify clinically relevant biomarkers. It is nowadays commonly used in clinical applications shedding new light on physiological regulatory processes of complex mammalian systems with regard to disease aetiology, diagnostic stratification and, potentially, mechanism of action of therapeutic solutions. A key feature of metabolomics lies in its ability to underpin the complex metabolic interactions of the host with its commensal microbial partners providing a new way to define individual and population phenotypes. This review aims at describing recent applications of metabolomics in clinical fields with insight into diseases, diagnostics/monitoring and improvement of homeostatic metabolic regulation.

[1]  J. Hunter,et al.  A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics , 2002, British Journal of Nutrition.

[2]  F. Guarner,et al.  Gut flora in health and disease , 2003, The Lancet.

[3]  J. Nicholson,et al.  Application of biofluid 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. , 2003, Analytical biochemistry.

[4]  Shelly C. Lu,et al.  Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. , 2010, Journal of proteome research.

[5]  J. Jansson,et al.  Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease , 2009, PloS one.

[6]  Kishore K. Pasikanti,et al.  Noninvasive urinary metabonomic diagnosis of human bladder cancer. , 2010, Journal of proteome research.

[7]  L. Ferguson,et al.  Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn's disease. , 2010, Journal of proteome research.

[8]  Olli Simell,et al.  Gender-dependent progression of systemic metabolic states in early childhood , 2008, Molecular systems biology.

[9]  K. Kaski,et al.  1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death , 2008, Molecular systems biology.

[10]  Marko Sysi-Aho,et al.  Acquired Obesity Is Associated with Changes in the Serum Lipidomic Profile Independent of Genetic Effects – A Monozygotic Twin Study , 2007, PloS one.

[11]  R. Bibiloni,et al.  Panorganismal gut microbiome-host metabolic crosstalk. , 2009, Journal of proteome research.

[12]  Ian D Wilson,et al.  HPLC-MS-based methods for the study of metabonomics. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  Oliver Fiehn,et al.  A comprehensive urinary metabolomic approach for identifying kidney cancerr. , 2007, Analytical biochemistry.

[14]  G. Berglund,et al.  Food patterns and components of the metabolic syndrome in men and women: a cross-sectional study within the Malmö Diet and Cancer cohort. , 2001, American journal of epidemiology.

[15]  R. Weindruch,et al.  Metabolic shifts due to long-term caloric restriction revealed in nonhuman primates , 2009, Experimental Gerontology.

[16]  C. Sawyers.  The cancer biomarker problem , 2008, Nature.

[17]  J. Gordon,et al.  How host-microbial interactions shape the nutrient environment of the mammalian intestine. , 2002, Annual review of nutrition.

[18]  J. Suvisaari,et al.  Metabolome in schizophrenia and other psychotic disorders: a general population-based study , 2011, Genome Medicine.

[19]  M. Milburn,et al.  Plasma metabolomic profile in nonalcoholic fatty liver disease. , 2011, Metabolism: clinical and experimental.

[20]  Johan Trygg,et al.  Chemometrics in metabonomics. , 2007, Journal of proteome research.

[21]  L. Tenori,et al.  The metabonomic signature of celiac disease. , 2009, Journal of proteome research.

[22]  C. Day,et al.  Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. , 1998, Journal of hepatology.

[23]  J. Johansson,et al.  Nuclear magnetic resonance-based metabolomics enable detection of the effects of a whole grain rye and rye bran diet on the metabolic profile of plasma in prostate cancer patients. , 2011, The Journal of nutrition.

[24]  William E. Kraus,et al.  Relationships Between Circulating Metabolic Intermediates and Insulin Action in Overweight to Obese, Inactive Men and Women , 2009, Diabetes Care.

[25]  Olli Simell,et al.  Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes , 2008, The Journal of experimental medicine.

[26]  Stephen J. Bruce,et al.  Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography/mass spectrometry. , 2009, Analytical chemistry.

[27]  Christian Gieger,et al.  Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting , 2010, PloS one.

[28]  E. Loftus.  Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. , 2004, Gastroenterology.

[29]  Cristina Andrés-Lacueva,et al.  Metabolomics unveils urinary changes in subjects with metabolic syndrome following 12-week nut consumption. , 2011, Journal of proteome research.

[30]  S. Bickston,et al.  Future therapies for inflammatory bowel disease , 2003, Current gastroenterology reports.

[31]  Daniel Raftery,et al.  Quantitative Metabolomics by 1H-NMR and LC-MS/MS Confirms Altered Metabolic Pathways in Diabetes , 2010, PloS one.

[32]  Timothy M. D. Ebbels,et al.  Intra- and inter-omic fusion of metabolic profiling data in a systems biology framework , 2010 .

[33]  J. Lindon,et al.  Topographical variation in murine intestinal metabolic profiles in relation to microbiome speciation and functional ecological activity. , 2009, Journal of proteome research.

[34]  W. Moon,et al.  An HR-MAS MR Metabolomics Study on Breast Tissues Obtained with Core Needle Biopsy , 2011, PloS one.

[35]  Ying Zhang,et al.  HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..

[36]  Jesús Brezmes,et al.  Metabolic phenotyping of genetically modified mice: An NMR metabonomic approach. , 2009, Biochimie.

[37]  J. Lindon,et al.  A metabolic system-wide characterisation of the pig: a model for human physiology. , 2011, Molecular bioSystems.

[38]  F. Shanahan,et al.  Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. , 2001, Gastroenterology.

[39]  Elaine Holmes,et al.  High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues , 2010, Nature Protocols.

[40]  U. Sharma,et al.  Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study. , 2009, Magnetic resonance imaging.

[41]  W. R. Wikoff,et al.  Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites , 2009, Proceedings of the National Academy of Sciences.

[42]  I. Wilson,et al.  Gut microorganisms, mammalian metabolism and personalized health care , 2005, Nature Reviews Microbiology.

[43]  S. Klein,et al.  Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications , 2010, Hepatology.

[44]  T. Ebbels,et al.  Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts , 2007, Nature Protocols.

[45]  Elaine Holmes,et al.  Susceptibility of human metabolic phenotypes to dietary modulation. , 2006, Journal of proteome research.

[46]  W. Kraus,et al.  Exercise-Induced Changes in Metabolic Intermediates, Hormones, and Inflammatory Markers Associated With Improvements in Insulin Sensitivity , 2010, Diabetes Care.

[47]  K. Fälth‐magnusson,et al.  Gut Microflora Associated Characteristics in Children with Celiac Disease , 2005, The American Journal of Gastroenterology.

[48]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[49]  John T. Wei,et al.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression , 2009, Nature.

[50]  Dirk Haller,et al.  Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice. , 2009, Journal of proteome research.

[51]  E. Hahn,et al.  Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease , 2002, American Journal of Gastroenterology.

[52]  S. Carr,et al.  Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. , 2011, The Journal of clinical investigation.

[53]  E. K. Kemsley,et al.  Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. , 2011, Journal of proteome research.

[54]  Christer S. Ejsing,et al.  Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry , 2009, Proceedings of the National Academy of Sciences.

[55]  S. Hazen,et al.  Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[S] , 2010, Journal of Lipid Research.

[56]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[57]  T. Murdoch,et al.  Urinary metabolic profiles of inflammatory bowel disease in interleukin-10 gene-deficient mice. , 2008, Analytical chemistry.

[58]  Xianlin Han,et al.  Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics , 2011, PloS one.

[59]  Bowei Xi,et al.  Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer. , 2011, Analytica chimica acta.

[60]  A. Ruigómez,et al.  Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study , 1999, BMJ.

[61]  Oliver Fiehn,et al.  Plasma Metabolomic Profiles Reflective of Glucose Homeostasis in Non-Diabetic and Type 2 Diabetic Obese African-American Women , 2010, PloS one.

[62]  Jeremiah Stamler,et al.  Metabolic profiling strategy for discovery of nutritional biomarkers: proline betaine as a marker of citrus consumption. , 2010, The American journal of clinical nutrition.

[63]  Takashi Ishikawa,et al.  Plasma Free Amino Acid Profiling of Five Types of Cancer Patients and Its Application for Early Detection , 2011, PloS one.

[64]  Ying Jiang,et al.  A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease. , 2011, Journal of proteome research.

[65]  E. Want,et al.  Colonization-Induced Host-Gut Microbial Metabolic Interaction , 2011, mBio.

[66]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[67]  E. Brunt,et al.  Nonalcoholic fatty liver disease: pathology and pathogenesis. , 2010, Annual review of pathology.

[68]  J. Lindon,et al.  Systems biology: Metabonomics , 2008, Nature.

[69]  S. Stannard,et al.  Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders , 2008, Hepatology.

[70]  Elaine Holmes,et al.  Transgenomic metabolic interactions in a mouse disease model: interactions of Trichinella spiralis infection with dietary Lactobacillus paracasei supplementation. , 2006, Journal of proteome research.

[71]  Douglas B Kell,et al.  Metabolomic biomarkers: search, discovery and validation , 2007, Expert review of molecular diagnostics.

[72]  J. Nicholson,et al.  Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology. , 2010, Journal of proteome research.

[73]  H. Vogel,et al.  Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by (1)H NMR spectroscopy. , 2010, Journal of proteome research.

[74]  G. Kollias,et al.  Metabolic phenotyping of the Crohn's disease-like IBD etiopathology in the TNF(ΔARE/WT) mouse model. , 2011, Journal of proteome research.

[75]  John C. Lindon,et al.  Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. , 2010, Journal of proteome research.

[76]  Ian D. Wilson,et al.  HIGH RESOLUTION PROTON MAGNETIC RESONANCE SPECTROSCOPY OF BIOLOGICAL FLUIDS , 1989 .

[77]  Elaine Holmes,et al.  A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model , 2007, Molecular systems biology.

[78]  K. Fraser,et al.  Identification of Urinary Biomarkers of Colon Inflammation in IL10−/− Mice Using Short-Column LCMS Metabolomics , 2010, Journal of biomedicine & biotechnology.

[79]  J. Malagelada,et al.  Metabotyping of biofluids reveals stress-based differences in gut permeability in healthy individuals. , 2009, Journal of proteome research.

[80]  Marc Chadeau-Hyam,et al.  Metabolome-wide association study identifies multiple biomarkers that discriminate north and south Chinese populations at differing risks of cardiovascular disease: INTERMAP study. , 2010, Journal of proteome research.

[81]  Matej Oresic,et al.  Metabolic Regulation in Progression to Autoimmune Diabetes , 2011, PLoS Comput. Biol..

[82]  I. Wilson,et al.  Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. , 2007, Journal of proteome research.

[83]  O. Fiehn,et al.  Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. , 2006, Cancer research.

[84]  D. Jewell,et al.  Characterization of Inflammatory Bowel Disease With Urinary Metabolic Profiling , 2009, The American Journal of Gastroenterology.

[85]  L. Ferguson,et al.  Using metabolomic analysis to understand inflammatory bowel diseases , 2011, Inflammatory bowel diseases.

[86]  M. Spraul,et al.  750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. , 1995, Analytical chemistry.

[87]  Serge Rezzi,et al.  Chemometric strategy for modeling metabolic biological space along the gastrointestinal tract and assessing microbial influences. , 2010, Analytical chemistry.

[88]  R. R. Singh,et al.  Similarity in the metabolic profile in macroscopically involved and un-involved colonic mucosa in patients with inflammatory bowel disease: an in vitro proton ((1)H) MR spectroscopy study. , 2010, Magnetic resonance imaging.

[89]  Svati H Shah,et al.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.

[90]  Z. Ramadan,et al.  Human metabolic phenotypes link directly to specific dietary preferences in healthy individuals. , 2007, Journal of proteome research.

[91]  R. Krauss,et al.  Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. , 2005, Cardiology in review.

[92]  G. Barbara,et al.  A role for inflammation in irritable bowel syndrome? , 2002, Gut.

[93]  Y. Fang,et al.  Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. , 2011, Journal of proteome research.